Health
Trial: No Need to Stop RAS Inhibitors in COVID-19 – MedPage Today
REPLACE COVID trial supports findings from BRACE CORONA
Hospitalized COVID-19 patients may safely continue taking their angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the small REPLACE COVID trial.
The study’s primary hierarchical endpoint — a global rank score in which patients were ranked by the severity of their COVID disease course according to various biomarkers and clinical events, with a lower rank score meaning more severe COVID-19 hospitalization — was about the same whether people were…
-
Noosa News13 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General12 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News16 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News15 hours agoPeter Dutton insists there’s enough water for his seven nuclear plants, contradicting shadow frontbencher